✦ LIBER ✦

Rethinking clinical trials for cytostatic drugs

✍ Scribed by Millar, Andrew W.; Lynch, Kevin P.

Book ID: 109946980
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 128 KB
Volume: 3
Category: Article
ISSN: 1474-1776
DOI: 10.1038/nrc1124

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genomics drugs in clinical trials

✍ Hall, Jonathan; Dennler, Patrick; Haller, Stephanie; Pratsinis, Anna; Säuberli, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 151 KB

Genomics drugs in clinical trials

✍ Hall, Jonathan; Dennler, Patrick; Haller, Stephanie; Pratsinis, Anna; Säuberli, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 84 KB

Drive for drugs leads to baby clinical t

Drive for drugs leads to baby clinical trials

📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 1013 KB

Clinical trial design for antiepileptic

Clinical trial design for antiepileptic drugs

✍ James J. Cereghino 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 2 views

In this issue of the Annals, Sachdeo and colleagues report on the efficacy of felbamate for partial onset seizures. They utilized a vahd active treatment control design, which was designed to show and did show a difference in efficacy 11). These results may be consid-

Antiangiogenic Drugs: From Bench to Clin

Antiangiogenic Drugs: From Bench to Clinical Trials

✍ Ana R. Quesada; Ramon Munoz-Chapuli; Miguel A. Medina 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB

METHODOLOGY OF CLINICAL DRUG TRIALS

✍ ANNE I. GOLDMAN 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views